» Articles » PMID: 16409156

Cd4+Cd25+ Regulatory T Cells and Their Therapeutic Potential

Overview
Journal Annu Rev Med
Publisher Annual Reviews
Specialty General Medicine
Date 2006 Jan 18
PMID 16409156
Citations 44
Authors
Affiliations
Soon will be listed here.
Abstract

The human immune system mounts specific responses to a vast array of antigens. Although this is clearly beneficial in fighting off harmful infections and cancerous cells, the system must be carefully controlled to ensure that normal self-antigens are not targeted. A recently characterized subset of T cells, identified by their cell surface expression of CD4 and CD25, is critical in regulating the function of other immune cells and preventing potentially harmful autoimmune responses. This article reviews what is currently known about these so-called regulatory T cells and discusses the therapeutic potential of these cells to modulate human immune-based diseases.

Citing Articles

Regulating the regulatory T cells as cell therapies in autoimmunity and cancer.

Hosseinalizadeh H, Rabiee F, Eghbalifard N, Rajabi H, Klionsky D, Rezaee A Front Med (Lausanne). 2023; 10:1244298.

PMID: 37828948 PMC: 10565010. DOI: 10.3389/fmed.2023.1244298.


Accumulation of pTreg cells is detrimental in late-onset (aged) mouse model of multiple sclerosis.

Wang W, Thomas R, Oh J, Su D Aging Cell. 2022; 21(6):e13630.

PMID: 35615905 PMC: 9197401. DOI: 10.1111/acel.13630.


The Molecular and Cellular Mechanisms Associated with a Microvascular Inflammation in the Pathogenesis of Heart Failure with Preserved Ejection Fraction.

Ovchinnikov A, Arefieva T, Potekhina A, Filatova A, Ageev F, Boytsov S Acta Naturae. 2020; 12(2):40-51.

PMID: 32742726 PMC: 7385098. DOI: 10.32607/actanaturae.10990.


Hyperfunction of CD4 CD25 regulatory T cells in de novo acute myeloid leukemia.

Wan Y, Zhang C, Xu Y, Wang M, Rao Q, Xing H BMC Cancer. 2020; 20(1):472.

PMID: 32456622 PMC: 7249438. DOI: 10.1186/s12885-020-06961-8.


Amlexanox attenuates experimental autoimmune encephalomyelitis by inhibiting dendritic cell maturation and reprogramming effector and regulatory T cell responses.

Quan M, Song X, Liu H, Deng X, Hou H, Chen L J Neuroinflammation. 2019; 16(1):52.

PMID: 30823934 PMC: 6396467. DOI: 10.1186/s12974-019-1438-z.